The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•7 April 2026•

1 min read

Global Influenza Vaccine Market Projected to Reach $9.38 Billion by 2026

Key Facts

1The influenza vaccines market size is projected to increase from USD 8.73 billion in 2025 to USD 9.38 billion in 2026.

2Quadrivalent vaccines held a dominant 71.68% share of the market in 2025.

The global influenza vaccine market is poised for steady growth through 2031, according to a recent report by Mordor Intelligence. Market valuation is expected to climb from USD 8.73 billion in 2025 to USD 9.38 billion by 2026. This expansion is largely driven by the dominance of quadrivalent vaccines, which held a significant 71.68% market share in 2025. Major pharmaceutical players, including Sanofi (SNY), GSK, and Pfizer (PFE), are well-positioned to benefit from the rising global demand for seasonal protection. The shift toward more advanced vaccine formulations continues to underpin the sector's long-term revenue potential. Consequently, the outlook for the healthcare sector and related ETFs like XLV remains positive as market adoption increases.

Create Free Account